MedTrace Logo

Patient Activation After DXA Result Notification

NCT01507662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7749

Last updated 2020-11-10

Study results available
· View outcomes & findings →

Summary

There is growing evidence that patients undergoing bone mineral density testing (BMD) often do not take important steps to improve their bone health. The investigators will conduct a randomized-controlled trial to evaluate the impact of a novel and practical patient activation intervention (mailing patients their bone density test results) on the quality of bone-related healthcare and the cost-effectiveness of BMD testing. Equally important, the investigators intervention could easily be modified to include other patient populations and chronic diseases.

Conditions

Interventions

BEHAVIORAL

Bone Mineral Density Result Letter and Bone Health Brochure

Letter mailed to patient to include - Date of DXA, T-score, impression, 10 year major fracture risk with visual depiction of risk, basic bone health guidelines, instructions to follow-up with their healthcare provider. The brochure will include information on osteoporosis, calcium, vitamin D, medicines, exercise, tobacco and alcohol cessation and where to find more information.

Sponsors & Collaborators

  • University of Alabama at Birmingham

    collaborator OTHER

  • Kaiser Permanente

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Fredric D Wolinsky

    lead OTHER

Principal Investigators

  • Fredric Wolinsky, PhD · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01507662 on ClinicalTrials.gov